ADHD Alcobra Ltd.

1.15
-0.03  -3%
Previous Close 1.18
Open 1.20
Price To book 0.69
Market Cap 31.70M
Shares 27,562,000
Volume 51,277
Short Ratio 1.97
Av. Daily Volume 463,031

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released January 17, 2017 - failed to meet primary endpoint.
MDX (Metadoxine Extended Release (MG01CI))
Adult ADHD
Phase 2b data released March 2015. Secondary cognitive measures did not produce statistically significant results.
MDX (Metadoxine Extended Release (MG01CI))
Pediatric ADHD
Phase 2 trial did not meet endpoints - June 2015.
MDX (Metadoxine Extended Release (MG01CI))
Fragile X Syndrome

Latest News

  1. Chuck Royce Continues to Buy These 10 Stocks
  2. Alcobra Announces Leadership Update
  3. Alcobra Provides Update on Cancellation of Extraordinary Meeting Called by Brosh Group
  4. Alcobra Mails Proxy Materials for Extraordinary General Meeting of Shareholders
  5. Exodus Capital is Summoning an Extraordinary General Meeting
  6. Tenax Therapeutics and Alcobra Find Rough Waters Ahead
  7. Alcobra Provides Update on Request for Extraordinary General Meeting
  8. SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Alcobra Ltd.
  9. DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm
  10. IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  11. Brosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman
  12. IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  13. SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  14. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
  15. SHAREHOLDER ALERT: SFMS Announces Filing of Securities Class Action Lawsuit Against Alcobra, Ltd.
  16. Alcobra Ltd. to Participate in Upcoming Healthcare Conferences
  17. INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm
  18. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  19. Alcobra to Host Investor Forum and Webcast on March 28 in New York City
  20. IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm